Formulation and Evaluation of Famotidine Gastro-Retentive Floating Matrix Tablets by Using Natural and Synthetic Polymers

Drugs that have narrow absorption window in the gastrointestinal tract (GIT) will have poor absorption. For these drugs, gastro retentive drug delivery systems offer the advantage in prolonging the gastric emptying time. Famotidine belongs to H2-receptor antagonist. It is used widely for the treatment of treatment of gastro-esophageal reflux disease (GERD) and gastric ulceration duodenal ulcer, stress ulcer. The low bioavailability (40-45 %) and short biological half-life (2.54.0 hrs) of Famotidine following oral administration favors development of a sustained release formulation. The rapid gastrointestinal transit could result in incomplete drug release from the drug delivery system above the absorption zone leading to poor bioavailability of the drug. The floating tablets were formulated using synthetic polymer like HPMC K15M and natural polymer like chitosan as the release retardant polymers, and sodium bicarbonate as the gas generating agent to reduce the floating lag time. The tablets were prepared by direct compression. The formulated tablets were evaluated for weight variation, hardness, friability, swelling index, floating lag time, total floating time and dissolution rate in pH 1.2. The floating tablets extended the drug release up to 12 h. The drugpolymer interaction was evaluated by Fourier transform infrared spectroscopy (FTIR). The FTIR study indicated the lack of drug-polymer interaction. The optimized formulation (F5), containing drug: HPMC K15M 200mg and Chitosan 75mg showed very good result and extended the release up to 12 h. The drug release from the optimized formulation followed Zero order kinetics and Korsmeyer Peppas equation. Sumit Gaikwad *1 , laxmi Jamagondi 2 , Baburao

[1]  K. Navaneetha,et al.  GASTRORETENTIVE DRUG DELIVERY SYSTEM- A REVIEW , 2016 .

[2]  H. Pawar,et al.  Development and Evaluation of Gastroretentive Floating Tablets of an Antihypertensive Drug Using Hydrogenated Cottonseed Oil , 2013, ISRN pharmaceutics.

[3]  G. K. Jani,et al.  Raft forming system-an upcoming approach of gastroretentive drug delivery system. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[4]  M. Sheu,et al.  Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities. , 2013, International journal of pharmaceutics.

[5]  B. Mishra,et al.  Floating Elementary Osmotic Pump Tablet (FEOPT) for Controlled Delivery of Diethylcarbamazine Citrate: a Water-Soluble Drug , 2011, AAPS PharmSciTech.

[6]  B. Kuchekar,et al.  Development and optimization of metoprolol succinate gastroretentive drug delivery system , 2010, Acta pharmaceutica.

[7]  Kenneth C. Waterman A Critical Review of Gastric Retentive Controlled Drug Delivery , 2007, Pharmaceutical development and technology.

[8]  Juergen Siepmann,et al.  Drug delivery to the upper small intestine window using gastroretentive technologies. , 2006, Current opinion in pharmacology.

[9]  R Manavalan,et al.  Development And In Vitro Evaluation Of An Oral Floating Matrix Tablet Formulation Of Ciprofloxacin , 2004 .

[10]  Brahma N. Singh,et al.  Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[11]  R. Bodmeier,et al.  Floating or pulsatile drug delivery systems based on coated effervescent cores. , 1999, International journal of pharmaceutics.

[12]  C. Rhodes,et al.  Development of a Novel Controlled-Release System for Gastric Retention , 1997, Pharmaceutical Research.

[13]  R. Ducret,et al.  Evaluation of the gastric retention properties of a cross-linked polymer coated tablet versus those of a non-disintegrating tablet , 1991 .

[14]  N. Verma,et al.  FLOATING DRUG DELIVERY SYSTEM: A REVIEW , 2014 .

[15]  I. Bashir,et al.  GASTRORETENTIVE DRUG DELIVERY SYSTEM: A REVIEW , 2014 .

[16]  A. V. Vidyapeetham FORMULATION AND EVALUATION OF OLMESARTAN MEDOXOMIL FLOATING TABLETS , 2013 .

[17]  S. Kakar,et al.  Magnetic microspheres as magical novel drug delivery system: A review , 2013 .

[18]  Paramita Saha,et al.  FLOATING DRUG DELIVERY SYSTEM , 2013 .

[19]  D. Jain,et al.  Preparation and in vitro evaluation of bilayer and fl oating-bioadhesive tablets of rosiglitazone maleate , 2007 .

[20]  J. Siepmann,et al.  Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  A. Moës Gastroretentive dosage forms. , 1993, Critical reviews in therapeutic drug carrier systems.

[22]  J. Robinson,et al.  Controlled Drug Delivery , 1986 .

[23]  R. Gröning,et al.  Oral Dosage Forms with Controlled Gastrointestinal Transit , 1984 .